K201814: BD FACSLyric Flow Cytometer (3-1, 4-2, 4-2-2, 4-3-3 and 4-3-5 optical configurations), BD FACSDuet Sample Preparation System, BD FACS Univer (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K201814 (BD FACSLyric Flow Cytometer (3-1, 4-2, 4-2-2, 4-3-3 and 4-3-5 optical configurations), BD FACSDuet Sample Preparation System, BD FACS Univer, cleared 2020-09-28 for Becton, Dickinson and Company) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K201814 |
| Cleared Device Trade / Generic Name | BD FACSLyric Flow Cytometer (3-1, 4-2, 4-2-2, 4-3-3 and 4-3-5 optical configurations), BD FACSDuet Sample Preparation System, BD FACS Univer |
| FDA Applicant on Filing | Becton, Dickinson and Company |
| FDA 3-Letter Product Classification | Product Code OYE |
| FDA Substantial Equivalence Decision Date | 2020-09-28 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Becton, Dickinson and Company (BD) across sibling Meru public-data platforms.
Inspect consolidated manufacturer lineage at Becton, Dickinson and Company, compare peer devices under FDA Product Code OYE, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.